Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) Income from Non-Controlling Interests: 2023-2025

Historic Income from Non-Controlling Interests for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Sep 2025 value amounting to $19.7 million.

  • Day One Biopharmaceuticals' Income from Non-Controlling Interests rose 154.56% to $19.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.3 million, marking a year-over-year increase of 73.74%. This contributed to the annual value of $88.4 million for FY2024, which is 53.23% down from last year.
  • Day One Biopharmaceuticals' Income from Non-Controlling Interests amounted to $19.7 million in Q3 2025, which was down 34.94% from $30.3 million recorded in Q2 2025.
  • Over the past 5 years, Day One Biopharmaceuticals' Income from Non-Controlling Interests peaked at $62.4 million during Q1 2024, and registered a low of -$36.2 million during Q3 2024.
  • In the last 3 years, Day One Biopharmaceuticals' Income from Non-Controlling Interests had a median value of $39.2 million in 2023 and averaged $31.7 million.
  • Per our database at Business Quant, Day One Biopharmaceuticals' Income from Non-Controlling Interests crashed by 178.34% in 2024 and then spiked by 962.07% in 2025.
  • Over the past 3 years, Day One Biopharmaceuticals' Income from Non-Controlling Interests (Quarterly) stood at $54.5 million in 2023, then rose by 8.68% to $59.2 million in 2024, then skyrocketed by 154.56% to $19.7 million in 2025.
  • Its Income from Non-Controlling Interests was $19.7 million in Q3 2025, compared to $30.3 million in Q2 2025 and $36.0 million in Q1 2025.